Expression of the mRNA levels for MDR1, MRP1, MRP4, and MRP5 in HIV antiretroviral naive patients : follow-up at 48 weeks after the beginning of therapy
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2011 |
---|---|
Erschienen: |
2011 |
Enthalten in: |
Zur Gesamtaufnahme - volume:56 |
---|---|
Enthalten in: |
Journal of acquired immune deficiency syndromes (1999) - 56(2011), 2 vom: 01. Feb., Seite e54-6 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Falasca, Francesca [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 16.02.2011 Date Revised 30.09.2020 published: Print Citation Status MEDLINE |
---|
doi: |
10.1097/QAI.0b013e3181fe4c89 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM205046223 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM205046223 | ||
003 | DE-627 | ||
005 | 20231223233200.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231223s2011 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1097/QAI.0b013e3181fe4c89 |2 doi | |
028 | 5 | 2 | |a pubmed24n0683.xml |
035 | |a (DE-627)NLM205046223 | ||
035 | |a (NLM)21233632 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Falasca, Francesca |e verfasserin |4 aut | |
245 | 1 | 0 | |a Expression of the mRNA levels for MDR1, MRP1, MRP4, and MRP5 in HIV antiretroviral naive patients |b follow-up at 48 weeks after the beginning of therapy |
264 | 1 | |c 2011 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 16.02.2011 | ||
500 | |a Date Revised 30.09.2020 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
650 | 4 | |a Letter | |
650 | 7 | |a ABCB1 protein, human |2 NLM | |
650 | 7 | |a ABCC4 protein, human |2 NLM | |
650 | 7 | |a ABCC5 protein, human |2 NLM | |
650 | 7 | |a ATP Binding Cassette Transporter, Subfamily B |2 NLM | |
650 | 7 | |a ATP Binding Cassette Transporter, Subfamily B, Member 1 |2 NLM | |
650 | 7 | |a Anti-HIV Agents |2 NLM | |
650 | 7 | |a Multidrug Resistance-Associated Proteins |2 NLM | |
650 | 7 | |a RNA, Messenger |2 NLM | |
650 | 7 | |a multidrug resistance-associated protein 1 |2 NLM | |
650 | 7 | |a Y49M64GZ4Q |2 NLM | |
700 | 1 | |a Maida, Paola |e verfasserin |4 aut | |
700 | 1 | |a Montagna, Claudia |e verfasserin |4 aut | |
700 | 1 | |a Antonelli, Laura |e verfasserin |4 aut | |
700 | 1 | |a d'Ettorre, Gabriella |e verfasserin |4 aut | |
700 | 1 | |a Monteleone, Katia |e verfasserin |4 aut | |
700 | 1 | |a Antonelli, Guido |e verfasserin |4 aut | |
700 | 1 | |a Turriziani, Ombretta |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of acquired immune deficiency syndromes (1999) |d 1999 |g 56(2011), 2 vom: 01. Feb., Seite e54-6 |w (DE-627)NLM101679912 |x 1944-7884 |7 nnns |
773 | 1 | 8 | |g volume:56 |g year:2011 |g number:2 |g day:01 |g month:02 |g pages:e54-6 |
856 | 4 | 0 | |u http://dx.doi.org/10.1097/QAI.0b013e3181fe4c89 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 56 |j 2011 |e 2 |b 01 |c 02 |h e54-6 |